These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15912456)

  • 1. [Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)].
    Jaissle GB; Szurman P; Bartz-Schmidt KU; ; ;
    Klin Monbl Augenheilkd; 2005 May; 222(5):390-5. PubMed ID: 15912456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the technique for intravitreal injections].
    Hammerstein W
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):210. PubMed ID: 17455390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravitreal injections--high standard of the procedure is necessary].
    Jaissle GB; Bartz-Schmidt KU
    Klin Monbl Augenheilkd; 2005 May; 222(5):389. PubMed ID: 15912455
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to perform intravitreal injections].
    Korobelnik JF; Cochereau I; Cohen SY; Coscas G; Creuzot-Garcher C; Devin F; Gaudric A; Mathis A; Mauget-Faÿsse M; Sahel JA; Soubrane G; Souied E; Weber M
    J Fr Ophtalmol; 2006 Jan; 29(1):82-6. PubMed ID: 16465129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technique of intravitreal drug injection for therapy of vitreoretinal diseases].
    Rodrigues EB; Maia M; Penha FM; Dib E; Bordon AF; Magalhães Júnior O; Farah ME
    Arq Bras Oftalmol; 2008; 71(6):902-7. PubMed ID: 19169531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of intravitreal injections].
    Gómez-Ulla F; Basauri E; Arias L; Martínez-Sanz F
    Arch Soc Esp Oftalmol; 2009 Aug; 84(8):377-88. PubMed ID: 19728238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the treatment of disturbing degenerative vitreous opacities : Status 20 November 2019].
    ; ;
    Ophthalmologe; 2020 Jul; 117(7):668-670. PubMed ID: 32415326
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)].
    Bartz-Schmidt KU; Bertram B; Bornfeld N; Bresgen M; Eter N; Feltgen N; Friedrichs W; Heimann H; Helbig H; Hoerauf H; Holz FG; Kampik A; Lemmen K; Lommatzsch A; Pauleikhoff D; Roider J; ; ;
    Klin Monbl Augenheilkd; 2013 Jun; 230(6):629-34. PubMed ID: 23794431
    [No Abstract]   [Full Text] [Related]  

  • 9. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada.
    Xing L; Dorrepaal SJ; Gale J
    Can J Ophthalmol; 2014 Jun; 49(3):261-6. PubMed ID: 24862772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).
    Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB
    Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statement of the Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on intravitreal treatment of vision-reducing macular edema by retinal vein occlusion : Treatment strategies, status 24 April 2018].
    ; ;
    Ophthalmologe; 2018 Oct; 115(10):842-854. PubMed ID: 30143857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].
    ; ;
    Ophthalmologe; 2018 May; 115(5):388-399. PubMed ID: 29572685
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the therapeutic use of voretigene neparvovec-rzyl (Luxturna™) in ophthalmology : Situation January 2019].
    ; ;
    Ophthalmologe; 2019 Jun; 116(6):524-533. PubMed ID: 31016385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Supplementary Statement on IVOM Drugs for the Treatment of Diabetic Macular Edema with Foveal Involvement - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].
    ; ;
    Klin Monbl Augenheilkd; 2023 Mar; 240(3):327-331. PubMed ID: 36977429
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of Ophthalmologists in Germany (BVA) on the timing of treatment of rhegmatogenous retinal detachment : Situation October 2020].
    ; ;
    Ophthalmologe; 2021 Mar; 118(3):235-238. PubMed ID: 33459809
    [No Abstract]   [Full Text] [Related]  

  • 16. Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of Ophthalmologists in Germany (BVA) on the timing of treatment of rhegmatogenous retinal detachment : Dated October 2020.
    ; ;
    Ophthalmologe; 2021 Jul; 118(Suppl 2):132-134. PubMed ID: 34232367
    [No Abstract]   [Full Text] [Related]  

  • 17. [Position Paper and Recommendations for Action for Ecologically Sustainable Ophthalmology - Statement of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)].
    ;
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):198-217. PubMed ID: 36812927
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].
    ; ;
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):180-189. PubMed ID: 36812925
    [No Abstract]   [Full Text] [Related]  

  • 19. Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration : Status February 2020.
    ; ;
    Ophthalmologe; 2021 Jan; 118(Suppl 1):31-39. PubMed ID: 32728806
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for progressive myopia in childhood and adolescence : Statement of the German Society of Ophthalmology (DOG) and the Professional Association of German Ophthalmologists (BVA). Status December 2018.
    ;
    Ophthalmologe; 2020 Jan; 117(Suppl 1):11-15. PubMed ID: 31455972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.